Finnish Foundation for Cardiovascular Research   Report issue

Foundation Phase 4
Founded: Finland

Organization Overview

First Clinical Trial
2011
NCT01479933
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Finnish Foundation for Cardiovascular Research

Active Ingredients

Drugs in Phase 4 Trials (1)

hydroxychloroquine (plaquenil) (1 trial)

Drugs in Other Trials (1)

vitamin d3 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Cardiovascular Diseases (Phase 4)

Infarction (Phase 4)

Inflammation (Phase 4)

Myocardial Infarction (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 2